[1]肖维,戴河柳,曹文雅,等.亮丙瑞林联合腹腔镜保守手术对卵巢子宫内膜异位症患者体内相关内分泌代谢和远期预后的影响[J].中国计划生育和妇产科,2019,(8):66-70.
 XIAO Wei,DAI He-liu,CAO Wen-ya,et al.Effect of leuprolide combined with laparoscopic conservative operation on related endocrine metabolism and long-term prognosis in patients with ovarian endometriosis[J].Chinese Journal of Family Planning & Gynecotokology,2019,(8):66-70.
点击复制

亮丙瑞林联合腹腔镜保守手术对卵巢子宫内膜异位症患者体内相关内分泌代谢和远期预后的影响
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年8期
页码:
66-70
栏目:
论著与临床
出版日期:
2019-08-25

文章信息/Info

Title:
Effect of leuprolide combined with laparoscopic conservative operation on related endocrine metabolism and long-term prognosis in patients with ovarian endometriosis
作者:
肖维戴河柳曹文雅夏美艳李侠*
湖北医药学院附属东风医院妇产科
Author(s):
XIAO Wei DAI He-liu CAO Wen-ya XIA Mei-yan LI Xia*
Department of Obstetrics and Gynecology, Dongfeng Hospital Affiliated to Hubei University of Medicine, Shiyan Hubei 442008, P.R.China
关键词:
亮丙瑞林腹腔镜手术卵巢子宫内膜异位症内分泌代谢远期预后
Keywords:
leuprolide laparoscopy surgery ovarian endometriosis endocrine metabolism long-term prognosis
分类号:
R 71171
摘要:
目的分析亮丙瑞林联合腹腔镜保守手术对卵巢子宫内膜异位症(endometriosis,EMs)患者体内相关内分泌代谢和远期预后的影响。方法选取2012年6月至2017年6月湖北医药学院附属东风医院收治的EMs患者80例为研究对象,按照随机数字表法分为观察组和对照组各40例。观察组在腹腔镜保守手术前采用亮丙瑞林治疗3个周期,对照组直接接受腹腔镜保守手术治疗,记录两组围术期情况、内分泌代谢指标、卵巢储备功能[卵巢体积、窦卵泡数(antral follicle count,AFC)]、不良反应、远期预后[术后6个
Abstract:
ObjectiveTo analyze the effects of leuprolide combined with laparoscopic surgery on related endocrine metabolism and long-term prognosis in patients with ovarian endometriosis (EMs). MethodsEighty patients with ovarian EMs admitted to Dongfeng Hospital Af

参考文献/References:

[1]GARGETT C E, SCHWAB K E, BROSENS J J, et al. Potential role of endometrial stem/progenitor cells in the pathogenesis of early-onset endometriosis [J]. Molecular Human Reproduction, 2014, 20(7): 591-598. [2]DAZ P U, STANGAFERRO M L, GAREIS N C, et al. Characterization of persistent follicles induced by prolonged treatment with progesterone in dairy cows:an experimental model for the study of(ovarianl follicular cysts [J]. Theriogenology, 2015, 84(7): 1149-1160. [3]RICCI E, VIGANO P, CIPRIANI S, et al. Physical activity andendometriosis risk in women with infertility or pain:Systematic review and meta-analysis [J]. Medicine, 2016, 95(40): e 1957. [4]龙平,洛若愚.腹腔镜联合醋酸亮丙瑞林治疗子宫内膜异位症合并不孕的临床效果[J].中国医药导报,2017,14(26):76-78. [5]中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症的诊治指南 [J].中华妇产科杂志,2015,50(3):161-169. [6]刘恋,于永斌,万金华,等.卵巢内异症囊肿病灶的解剖特征及其与疼痛症状的相关性研究[J].局解手术学杂志,2014,23(5):537-539. [7]KURMAN R J, BANET N. Two types of ovarian cortical inclusion cysts:proposed origin and possible role in ovarian serous carcinogenesis[J]. International Journal of Gynecological Pathology, 2015, 34(3): 304-305. [8]SHIBA E, YAMASHITA H, KUREBAYASHI J, et al. A randomized controlled study evaluating safety and efficacy of le-uprorelin acetate every-3-months depot for 2 versus 3 ormore years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrineresponsivebreast cancer [J]. Breast Cancer, 2016, 23(3): 1-11. [9]温方圆.腹腔镜下卵巢子宫内膜异位症囊肿剥除术前使用亮丙瑞林治疗对卵巢储备功能的保护效果研究 [J].中国妇幼保健,2016,31(8):1752-1754. [10]杨扬,黄飞翔.腹腔镜下卵巢子宫内膜异位症囊肿剥除术前应用亮丙瑞林微球对卵巢储备功能的保护效果 [J].中国生化药物杂志,2016,36(8):55-57. [11]KHAN K N, KITAJIMA M, HIRAKI K, et al. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy [J]. Human Reproduction (Oxford, England), 2010, 25(3): 642-653. [12]KHAN K N, KITAJIMA M, HIRAKI K, et al. Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma[J]. Human Reproduction (Oxford, England), 2010, 25(11): 2878-2890. [13]沈栗帆,何艳,季菲,等.醋酸亮丙瑞林对子宫内膜异位症内分泌水平及骨密度的影响 [J].新疆医科大学学报,2017,40(2):170-173. [14]陈廷飞,张燕.腹腔镜手术联合亮丙瑞林治疗重度子宫内膜异位症的临床分析 [J].江苏医药,2015,41(21):2595-2596. [15]黄淑娴,曹欢欢,程雪菊,等.腹腔镜下卵巢子宫内膜异位症囊肿剥除术前应用亮丙瑞林微球的效果及对卵巢储备功能的影响 [J].临床和实验医学杂志,2017,16(22):2232-2235. [16]董建新,白洁,陈燕.亮丙瑞林微球蛋白联合腹腔镜手术对子宫内膜异位症的疗效及预后影响 [J].西部医学,2017,29(5):662-665. [17]WuD, HU M, HONG L, et al. Clinical efficacy of add-back therapyArch Gynecol 0b-in treatment of endometriosis:a meta-analysis [J]. Stet, 2014, 290(3): 513-523. [18]金海红,赖筱琍.腹腔镜联合亮丙瑞林在子宫内膜异位症治疗中的应用 [J].中国妇幼保健,2017,32(7):1562-1565. [19]李妮,李花繁,李维玲,等.醋酸亮丙瑞林微球治疗子宫内膜异位症效果研究 [J].中国性科学,2016,25(11):32-35.

相似文献/References:

[1]喻海芬,熊毅刚.腹腔镜诊治计划生育手术并发症32例临床分析[J].中国计划生育和妇产科,2009,(06):0.
[2]张榑,马葆荣,薛润清,等.子宫肌瘤切除三种术式临床效果比较[J].中国计划生育和妇产科,2010,(02):0.
 ZHANG Fu,MA Bao-rong,XUE Run-qing.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(8):0.
[3]刘彩艳.宫角妊娠34例诊治分析[J].中国计划生育和妇产科,2010,(04):0.
[4]吕建利,郑红艳.腹腔镜治疗卵巢成熟性囊性畸胎瘤42例分析[J].中国计划生育和妇产科,2010,(04):0.
[5]宋治兰,贺进,钱碧慧,等.腹腔镜辅助盆底重建术治疗子宫脱垂的临床疗效分析[J].中国计划生育和妇产科,2010,(05):0.
 SONG Zhi-lan,HE Jin,QIAN Bi-hui.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(8):0.
[6]蒋芝蓉,罗光楠.腹腔镜下腹膜阴道成形术342例报道[J].中国计划生育和妇产科,2011,(01):0.
 JIANG Zhi-rong,LUO Guang-nan.Chengdu Sunshine Gynecology Hospital,Chengdu Sichuan 00,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(8):0.
[7]刘莉.腹腔镜下不同术式子宫肌瘤切除术51例分析[J].中国计划生育和妇产科,2011,(01):0.
 LIU Li.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(8):0.
[8]马建婷,杨春林,苏雪锋,等.腹腔镜子宫内膜异位囊肿剔除术两种止血方法对年轻患者卵巢储备功能的影响[J].中国计划生育和妇产科,2011,(02):0.
 MA Jian-ting,YANG Chun-lin,SU Xue-feng,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(8):0.
[9]黄文华.腹腔镜下全子宫切除术的临床分析[J].中国计划生育和妇产科,2011,(02):0.
[10]林永红,李万珍,刘莉,等.悬吊式无气腹腹腔镜巨大子宫肌瘤切除术的初步观察及文献复习[J].中国计划生育和妇产科,2011,(04):0.
 LIN Yong-hong,LI Wan-zhen,LIU Li,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(8):0.

备注/Memo

备注/Memo:
湖北省社会科学基金项目(项目编号:[2011]029)
更新日期/Last Update: 2019-08-25